What is WeeFeel?
Founded in 2019, WeeFeel operates at the intersection of healthtech and subscription commerce. By leveraging a data-driven approach to supplement delivery, the company provides consumers with tailored wellness blends delivered directly to their doorsteps. This model addresses the growing demand for convenience and personalization in the health sector, positioning WeeFeel as a key player in the UK's burgeoning D2C wellness market. The company's operational framework focuses on high-frequency engagement through its subscription platform, ensuring consistent recurring revenue while maintaining a lean, agile supply chain that prioritizes customer retention and brand loyalty.
How much funding has WeeFeel raised?
WeeFeel has raised a total of $17.6M across 2 funding rounds:
Series A
$6.3M
Series A
$11.3M
Series A (2021): $6.3M with participation from Tmt Investments and Fuel Ventures
Series A (2022): $11.3M led by Fuel Ventures, Tmt Investments, and Velocity Capital Advisors
Key Investors in WeeFeel
Fuel Ventures
Fuel Ventures is a UK-based venture capital firm that specializes in supporting ambitious technology companies with early commercial traction, providing both capital and operational expertise.
Tmt Investments
TMT Investments is a publicly traded global firm focused on identifying and scaling early-stage technology startups across sectors like SaaS, Fintech, and Healthtech.
Velocity Capital Advisors
Velocity Capital Advisors facilitates participation in innovative, high-growth technology companies, taking an active role in the strategic development of its portfolio businesses.
What's next for WeeFeel?
With this major enterprise-level funding, WeeFeel is well-positioned to accelerate its growth trajectory and expand its operational footprint. The strategic allocation of this capital will likely focus on scaling the company's logistics infrastructure to support increased demand, enhancing its digital platform for a more personalized user experience, and potentially exploring new product categories within the broader health and wellness ecosystem. As the company transitions from its early-stage development into a more mature scaling phase, the focus will shift toward optimizing customer acquisition costs and solidifying its presence in the competitive European healthtech landscape. The continued support from its institutional backers suggests a long-term commitment to WeeFeel's vision of modernizing the supplement industry through technology-enabled convenience.
See full WeeFeel company page
